Ethanolamine

CAS No. 141-43-5

Ethanolamine( 2-Aminoethanol | monoethanolamine | 2-Hydroxyethylamine )

Catalog No. M19560 CAS No. 141-43-5

2-Aminoethanol (ethanolamine) can inhibit the GABA degrading enzyme GABA aminotransferase (GABA-T).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ethanolamine
  • Note
    Research use only, not for human use.
  • Brief Description
    2-Aminoethanol (ethanolamine) can inhibit the GABA degrading enzyme GABA aminotransferase (GABA-T).
  • Description
    2-Aminoethanol (ethanolamine) can inhibit the GABA degrading enzyme GABA aminotransferase (GABA-T). Strengthening of the antioxidant mechanisms by plant pretreatment with 2-aminoethanol could be helpful in the development of a broad tolerance to adverse stress conditions.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    2-Aminoethanol | monoethanolamine | 2-Hydroxyethylamine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    GABA transaminase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    141-43-5
  • Formula Weight
    61.08
  • Molecular Formula
    C2H7NO
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    NCCO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.L?scher W. Effect of 2-aminoethanol on the synthesis binding uptake and metabolism of GABA. Neurosci Lett. 1983 Dec 11;42(3):293-7.
molnova catalog
related products
  • DX3-213B

    DX3-213B is a potent, orally active inhibitor of oxidative phosphorylation (OXPHOS) complex I with an IC50 of 3.6 nM.

  • PAR-3 (1-6) (human)

    PAR3 (1-6) is a synthetic peptide agonist of proteinase-activated receptor 1 (PAR1) that corresponds to residues 1-6 of the amino terminal tethered ligand sequence of human PAR3 and residues 39-44 of the full-length human sequence. PAR3 (1-6) activates p42/44 MAPK signaling in fibroblasts expressing PAR1, but not PAR3, an effect that can be blocked by the PAR1 antagonist RWJ 56110.

  • [Nle10]-Neurokinin A...

    [Nle10]-Neurokinin A (4-10)